PharmacoDB

Home/
Explore/

Explore PharmacoDB!

Step 1: select tissues / targets

cell lines

Alexander cells

G-292;clone A141B1

Ishikawa (Heraklio) 02 ER-

Jurkat;Clone E6-1

LNCaP-Clone-FGC

MKL-1-subclone-2

PE/CA-PJ34 (clone C12)

PE/CA-PJ41 (clone D2)

drugs

(5Z)-7-Oxozeaenol

16-beta-bromoandrosterone

AKT inhibitor VIII

alisertib:navitoclax (2:1 mol/mol)

avrainvillamide

bardoxolone methyl

Bax channel blocker

BRD-A02303741:carboplatin (1:1 mol/mol)

BRD-A02303741:navitoclax (2:1 mol/mol)

BRD-K27188169:navitoclax (2:1 mol/mol)

BRD9876:MK-1775 (4:1 mol/mol)

carboplatin:etoposide (40:17 mol/mol)

carboplatin:UNC0638 (2:1 mol/mol)

Compound 23 citrate

Compound 7d-cis

crizotinib:PLX-4032 (2:1 mol/mol)

cyanoquinoline 11

Cyclophosphamide

decitabine:carboplatin (1:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

docetaxel:tanespimycin (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

epigallocatechin-3-monogallate

ERKi II (FR180304)

erlotinib:PLX-4032 (2:1 mol/mol)

FTase inhibitor I

Genentech Cpd 10

GSK-3 inhibitor IX

Ibandronate sodium salt

isoliquiritigenin

isonicotinohydroxamic acid

ISOX:bortezomib (250:1 mol/mol)

Ispinesib Mesylate

JNK Inhibitor VIII

JQ-1:carboplatin (1:1 mol/mol)

JQ-1:MK-0752 (1:1 mol/mol)

JQ-1:navitoclax (2:1 mol/mol)

JQ-1:UNC0638 (2:1 mol/mol)

JQ-1:vorinostat (2:1 mol/mol)

Lestaurtinib(CEP-701)

marinopyrrole A

ML334 diastereomer

N9-isopropylolomoucine

navitoclax:birinapant (1:1 mol/mol)

navitoclax:gemcitabine (1:1 mol/mol)

navitoclax:MST-312 (1:1 mol/mol)

navitoclax:piperlongumine (1:1 mol/mol)

navitoclax:pluripotin (1:1 mol/mol)

navitoclax:PLX-4032 (1:1 mol/mol)

navitoclax:sorafenib (1:1 mol/mol)

necrosulfonamide

O-6-benzylguanine

Obatoclax Mesylate

omacetaxine mepesuccinate

PF-4800567 hydrochloride

pifithrin-alpha

piperlongumine:MST-312 (1:1 mol/mol)

PRL-3 Inhibitor I

prochlorperazine

pyrazolanthrone

S-Trityl-L-cysteine

salermide:PLX-4032 (12:1 mol/mol)

selumetinib:BRD-A02303741 (4:1 mol/mol)

selumetinib:decitabine (4:1 mol/mol)

selumetinib:GDC-0941 (4:1 mol/mol)

selumetinib:JQ-1 (4:1 mol/mol)

selumetinib:MK-2206 (8:1 mol/mol)

selumetinib:navitoclax (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:PLX-4032 (8:1 mol/mol)

selumetinib:tretinoin (2:1 mol/mol)

selumetinib:UNC0638 (4:1 mol/mol)

selumetinib:vorinostat (8:1 mol/mol)

serdemetan:SCH-529074 (1:1 mol/mol)

Sigma AKT1-2 inhibitor

sirolimus:bortezomib (250:1 mol/mol)

SNX-2112:bortezomib (250:1 mol/mol)

Sunitinib Malate

tanespimycin:bortezomib (250:1 mol/mol)

tanespimycin:gemcitabine (1:1 mol/mol)

TCS2312 dihydrochloride

tretinoin:carboplatin (2:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

triazolothiadiazine

trifluoperazine

Tykerb:IGF1R (1:1)

UNC0638:navitoclax (1:1 mol/mol)

vorinostat:carboplatin (1:1 mol/mol)

vorinostat:navitoclax (4:1 mol/mol)

targets